P
Philip A. Poole-Wilson
Researcher at National Institutes of Health
Publications - 443
Citations - 69648
Philip A. Poole-Wilson is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Heart disease. The author has an hindex of 105, co-authored 443 publications receiving 66861 citations. Previous affiliations of Philip A. Poole-Wilson include Harefield Hospital & St George's Hospital.
Papers
More filters
Journal ArticleDOI
Skeletal Muscle Function and Its Relation to Exercise Tolerance in Chronic Heart Failure
Derek Harrington,Stefan D. Anker,Stefan D. Anker,T. P. Chua,Katharine Webb-Peploe,Piotr Ponikowski,Philip A. Poole-Wilson,Andrew J.S. Coats +7 more
TL;DR: In patients with chronic HF, quadriceps maximal isometric strength is reduced and muscular atrophy becomes a major determinant of exercise capacity and is an independent predictor of peak absolute VO2.
Journal ArticleDOI
Coronary artery disease as the cause of incident heart failure in the population
Kevin Fox,Martin R. Cowie,David R. Wood,Andrew J.S. Coats,J S R Gibbs,S. R. Underwood,Rebecca M. Turner,Philip A. Poole-Wilson,S.W Davies,George C. Sutton +9 more
TL;DR: Coronary artery disease is the cause of 52% (95% CI 43-61%) of incident heart failure in the general population under 75 years and clinical assessment without angiography under-estimates the proportion of patients with coronary artery disease, and fails to identify those patients who may benefit from revascularization.
Journal ArticleDOI
Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro
TL;DR: It is suggested that a calcium antagonistic property may be involved in the mechanism of rabbit coronary arterial relaxation by 17β‐oestradiol by an endothelium‐independent mechanism in vitro.
Journal ArticleDOI
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure.
Stefan D. Anker,Stefan D. Anker,Karl Egerer,Karl Egerer,Hans-Dieter Volk,Hans-Dieter Volk,Wolfgang J. Kox,Wolfgang J. Kox,Philip A. Poole-Wilson,Philip A. Poole-Wilson,Andrew J.S. Coats,Andrew J.S. Coats +11 more
TL;DR: Patients with high soluble CD14 levels have markedly increased plasma levels of TNF-alpha, soluble TNF receptors 1 and 2, and intracellular adhesion molecule-1, supporting this hypothesis that in patients with chronic heart failure mesenteric venous congestion leads to increased bowel permeability, bacterial translocation, and thereby endotoxin release.
Journal ArticleDOI
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial
Keith A.A. Fox,Philip A. Poole-Wilson,Tim Clayton,Robert A. Henderson,T. R. D. Shaw,D J Wheatley,Rosemary Knight,Stuart J. Pocock +7 more
TL;DR: In patients with non-ST-elevation acute coronary syndrome, a routine invasive strategy leads to long-term reduction in risk of death or non-fatal myocardial infarction, and this benefit is mainly in high-risk patients.